首页> Pulmonary pharmacology & therapeutics> Epigallocatechin-3-gallate augments antioxidant activities and inhibits inflammation during bleomycin-induced experimental pulmonary fibrosis through Nrf2-Keap1 signaling.

Epigallocatechin-3-gallate augments antioxidant activities and inhibits inflammation during bleomycin-induced experimental pulmonary fibrosis through Nrf2-Keap1 signaling.

导出原文传递

翻译打印收藏纠错

作者： Sriram N ^[1] ; Kalayarasan S ; Sudhandiran G

作者单位： Department of Biochemistry, University of Madras, Guindy Campus, Chennai 600 025, Tamilnadu, India. ^[1]

关键词 Bleomycin Kea Inflammation Antioxidants p1 *博来霉素炎症抗氧化药

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

Pulmonary pharmacology & therapeutics

2009年22卷3期

221-236页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览1

点击下载本期目录封面

Pulmonary pharmacology & therapeutics

2009年22卷3期

221-236页

检索历史清除

Epigallocatechin-3-gallate augments antioxidant activities and inhibits inflammation during bleomycin-induced experimental pulmonary fibrosis through Nrf2-Keap1 signaling.

Pulmonary pharmacology & therapeutics

相似文献

Pulmonary pharmacology & therapeutics

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Epigallocatechin-3-gallate augments antioxidant activities and inhibits inflammation during bleomycin-induced experimental pulmonary fibrosis through Nrf2-Keap1 signaling.

Pulmonary pharmacology & therapeutics

相似文献

Pulmonary pharmacology & therapeutics

相关期刊

检索历史清除